Moderna logo

Moderna (MRNA) Q4 2024 Annual Earnings

MRNA·Reported February 14, 2025·Before market open

Moderna reported Q4 2024 revenue of $956.0M, beat analyst consensus of $942.8M by $13.2M. Diluted EPS came in at $-2.50, beat the $-2.68 consensus by $0.18.

Revenue
$956.0Mbeat by $13.2M
Consensus: $942.8M
Diluted EPS
$-2.50beat by $0.18
Consensus: $-2.68
SEC

SEC Filings

Earnings release8-K · 0001682852-25-000006
Annual report10-K · 0001682852-25-000022

Financial Snapshot

Trailing eight quarters through Q4 2024

View all metrics

Revenue

View metric

Net Income

View metric

Operating Cash Flow

View metric

EPS (Diluted)

View metric

Q4 2024 Earnings FAQ

Common questions about Moderna's Q4 2024 earnings report.

Moderna (MRNA) reported Q4 2024 earnings on February 14, 2025 before market open.

Moderna reported revenue of $956.0M and diluted EPS of $-2.50 for Q4 2024.

Revenue beat the consensus estimate of $942.8M by $13.2M. EPS beat the consensus estimate of $-2.68 by $0.18.

You can read the 8-K earnings release (0001682852-25-000006) and the 10-K periodic report (0001682852-25-000022) directly on SEC EDGAR. The filing index links above go to sec.gov.